80 related articles for article (PubMed ID: 17557264)
21. Expression and characterization of a human BMP-7 variant with improved biochemical properties.
Swencki-Underwood B; Mills JK; Vennarini J; Boakye K; Luo J; Pomerantz S; Cunningham MR; Farrell FX; Naso MF; Amegadzie B
Protein Expr Purif; 2008 Feb; 57(2):312-9. PubMed ID: 17977014
[TBL] [Abstract][Full Text] [Related]
22. Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand.
Saremba S; Nickel J; Seher A; Kotzsch A; Sebald W; Mueller TD
FEBS J; 2008 Jan; 275(1):172-83. PubMed ID: 18070108
[TBL] [Abstract][Full Text] [Related]
23. Can TGF-beta1 and rhBMP-2 act in synergy to transform bone marrow stem cells to discogenic-type cells?
Kuh SU; Zhu Y; Li J; Tsai KJ; Fei Q; Hutton WC; Yoon ST
Acta Neurochir (Wien); 2008 Oct; 150(10):1073-9; discussion 1079. PubMed ID: 18781274
[TBL] [Abstract][Full Text] [Related]
24. Bone morphogenetic proteins 1 to 7 in human breast cancer, expression pattern and clinical/prognostic relevance.
Davies SR; Watkins G; Douglas-Jones A; Mansel RE; Jiang WG
J Exp Ther Oncol; 2008; 7(4):327-38. PubMed ID: 19227012
[TBL] [Abstract][Full Text] [Related]
25. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats.
Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC
Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244
[TBL] [Abstract][Full Text] [Related]
26. Systemically administered bone morphogenetic protein-6 restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone resorption.
Simic P; Culej JB; Orlic I; Grgurevic L; Draca N; Spaventi R; Vukicevic S
J Biol Chem; 2006 Sep; 281(35):25509-21. PubMed ID: 16798745
[TBL] [Abstract][Full Text] [Related]
27. Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia.
Jara A; Chacón C; Burgos ME; Droguett A; Valdivieso A; Ortiz M; Troncoso P; Mezzano S
Nephrol Dial Transplant; 2009 Apr; 24(4):1121-9. PubMed ID: 19028757
[TBL] [Abstract][Full Text] [Related]
28. Faulty bone morphogenetic protein signaling in esophageal atresia with tracheoesophageal fistula.
Crowley AR; Mehta SS; Hembree MJ; Preuett BL; Prasadan KL; Sharp SW; Yew H; McFall CR; Benjes CL; Tulachan SS; Gittes GK; Snyder CL
J Pediatr Surg; 2006 Jul; 41(7):1208-13. PubMed ID: 16818050
[TBL] [Abstract][Full Text] [Related]
29. Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix.
Han D; Liu W; Ao Q; Wang G
Med Hypotheses; 2008 Sep; 71(3):374-8. PubMed ID: 18565684
[TBL] [Abstract][Full Text] [Related]
30. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
[TBL] [Abstract][Full Text] [Related]
31. Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions.
Fuller ML; DeChant AK; Rothstein B; Caprariello A; Wang R; Hall AK; Miller RH
Ann Neurol; 2007 Sep; 62(3):288-300. PubMed ID: 17696121
[TBL] [Abstract][Full Text] [Related]
32. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
Ye L; Lewis-Russell JM; Kynaston H; Jiang WG
J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
[TBL] [Abstract][Full Text] [Related]
33. Tetramethylpyrazine inhibits agiontensin II-induced nuclear factor-kappaB activation and bone morphogenetic protein-2 downregulation in rat vascular smooth muscle cells.
Ren XY; Ruan QR; Zhu DH; Zhu M; Qu ZL; Lu J
Sheng Li Xue Bao; 2007 Jun; 59(3):339-44. PubMed ID: 17579790
[TBL] [Abstract][Full Text] [Related]
34. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering.
Yilgor P; Tuzlakoglu K; Reis RL; Hasirci N; Hasirci V
Biomaterials; 2009 Jul; 30(21):3551-9. PubMed ID: 19361857
[TBL] [Abstract][Full Text] [Related]
35. Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin.
Kodama T; Goto T; Miyazaki T; Takahashi T
Int J Oral Maxillofac Implants; 2008; 23(6):1013-9. PubMed ID: 19216269
[TBL] [Abstract][Full Text] [Related]
36. Weekly intra-articular injections of bone morphogenetic protein-7 inhibits osteoarthritis progression.
Hayashi M; Muneta T; Ju YJ; Mochizuki T; Sekiya I
Arthritis Res Ther; 2008; 10(5):R118. PubMed ID: 18826579
[TBL] [Abstract][Full Text] [Related]
37. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells.
Seib FP; Franke M; Jing D; Werner C; Bornhäuser M
Eur J Cell Biol; 2009 May; 88(5):257-71. PubMed ID: 19303661
[TBL] [Abstract][Full Text] [Related]
38. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery.
Jeon O; Song SJ; Yang HS; Bhang SH; Kang SW; Sung MA; Lee JH; Kim BS
Biochem Biophys Res Commun; 2008 May; 369(2):774-80. PubMed ID: 18313401
[TBL] [Abstract][Full Text] [Related]
39. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
40. [Effects of injuries pulmonary arterial endothelial cell induced by endotoxin on proliferation of pulmonary artery smooth muscle cells and interference effect of bone morphogenetic protein-2].
Pei L; Shan SM; Sun XY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):40-5. PubMed ID: 18346379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
